Learning Biology is an evolving process. The science keeps changing towards a greater understanding and sometimes the conclusions that were drawn are not always right. For example, blood letting or bleeding a person used to be the treatment for some diseases. That was an acceptable form of treatment but now we wonder as to what led to those conclusions? It is difficult to be just 100% right all the time. When a scientist makes a specific theory, it is based upon the data that is available at that time. If that data changes over the period or some new information comes in then the theory has to change. As scientists, we beat ourselves up on being right 100% of the time and if that is what we aim for then it would be impossible to conclude anything and we would just want to be quiet and live in a cave without concluding anything. However, the good scientists try’s to find the interesting (which may also vary) things in the world and work on them. There is another catch here: if they work on something that is just “cool” and has a lot of other scientists working on them, then there will be no differentiator. A good scientist will try to discover and work on interesting things to work on that are interesting to them and are cool but is the kind of thing that no one is paying much attention to…
Similar Posts
3D Anatomy
There are so many ways to visualize complex data AND understand it at the same time. However, this has been done for many years for complex data using diagrams.A typical place this has done many times has been anatomy. These diagrams present the views from different viewpoints and these then create the understanding of the…
Molecularly imprinted polymers
This is an approach to design polymers that recognize materials which may be of biological origin. Their advantage is their high selectivity and affinity for the target molecule. The high level view of the process to create such a polymer is relatively simple though the devil may be in the details. In the presence of…
Biomarkers in Inflammatory bowel disease with antibody therapy
Two types of inflammatory bowel disease, Ulcerative colitis and Crohn’s disease. A challenge in IBD development is that many drugs show systemic PK and PD but fail in the intestinal mucosa. Most companies focus on Ulcerative colitis due to a) homogenous biology, b) access to tissue, c) established endpoints and d) lower variability in translational…
Synthetic biology dyes
A synthetic biology company called Huue is going forward to create dye’s from bacteria. The cool part is that they are taking machinery that is in plants and introducing them into bacteria.An advantage is that you could manipulate and then come up with new dyes. The dye Huue has started with is called Indigo and…
